SIEGALL CLAY B (President and CEO) purchased 0.9% of their position (7.28K shares) of IMMUNOME INC. on the open market
Open‑market purchase worth $149.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/22/2025ACC: 0001167496-25-000008
DirectorOfficer· President and CEO
Since Oct 2023
-192.72K
Net shares
Net seller
$149.1K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
7.28K acquired · 200K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.28K
Price / share
$20.48
Trade value
$149.05K
% of position
0.9%
12/19/2025
853.25K→860.52K
Common Stock
Direct
Shares
−200K
Price / share
—
Trade value
—
% of position
23.2%
12/19/2025
860.52K→660.52K
Total
Net shares
−192.72K
Net value
$149.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | P · Purchase | +7.28K | $20.48 | $149.05K | 0.9% | 853.25K | 860.52K |
| Common Stock Direct | 12/19/2025 | G · Gift | −200K | — | — | 23.2% | 860.52K | 660.52K |
| Total | −192.72K | $149.05K | ||||||
Derivative Transactions0
No derivative transactions reported